NEW DELHI: Primary Vaccine Serum institute India on Sunday rejected allegations that a Covid-19 candidate vaccine has serious side effects and threatened to seek large compensation for “malicious” allegations.
A 40-year-old man who took part in the ‘Covidshield’ vaccine trial in Chennai has alleged serious side effects, including virtual neurological collapse and impaired cognitive functions, and has applied for Rs 5 million compensation in a legal notice. to the Serum Institute and others, in addition to seeking the cessation of the trial.
“The allegations in the ad are malicious and ill-conceived. While the Serum Institute of India is sympathetic to the medical condition of the volunteer, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer,” said Serum Institute of India in a statement. statement.
The volunteer falsely blames his medical problems on the Covid-19 vaccine trial, he added.
“It is clear that the intent behind the dissemination of such malicious information is an indirect pecuniary motive. The Serum Institute of India will seek damages in excess of 100 crore for the same and will defend such malicious claims,” said Serum Institute.
Pune-based Serum Institute of India (SII) has collaborated with Oxford University and pharmaceutical company Astra Zeneca to manufacture the Covid-19 vaccine, ‘Covidshield,’ and is conducting trials in India.
.
